Nutritional Growth Solutions Ltd. · ASX:NGS

Nutritional Growth Solutions — Investor Presentation (August 2024)

15 slides from Nutritional Growth Solutions's investor presentation, Aug 30, 2024

  1. Slide 1: Nutritional Growth Solutions (ASX: NGS) 1H FY24 Results

    Investor Presentation 30 August 2024 Nutritional Growth Solutions (ASX: NGS) 1H FY24 Results

  2. Slide 2: Disclaimer

    2 Disclaimer These presentation materials (the Presentation Materials) are confidential and have been prepared by Nutritional Growth Solutions (Company). By receiving the Presentation Materials, you acknowledge and represent to the Company that you have read, understood and accepted the terms of thi

  3. Slide 3: Strategic Imperatives

    3 Strategic Imperatives Targeting break-even in 1H FY25, and achieving US$380k in Avg. Monthly Revenue with 43% Gross Margin in near term. Near Term Revenue Goal: US$380k/month Gross Margin Target: >50% • Historically achieved US$300k/month in Q1 FY23. • 1H FY24 adjusted Gross Margin was 38%1, proje

  4. Slide 4: Financial Results

    4 Financial Results USD $000’s 1H FY24 1H FY23 Revenue Impacted by Supply Chain Disruption • 1H FY24 revenue of US$1.25m was down 18% YoY, constrained by limited Revenue 1,247 1,521 working capital and a shortage of sunflower oil; leading to ~30% of sales Cost of Revenue 863 901 orders being unfulfi

  5. Slide 5: Balance Sheet and Cash Management

    5 Balance Sheet and Cash Management Recapitalised to Return to Growth USD $000’s 1H FY24 1H FY23 Current Assets • NGS held US$128,000 in cash reserves as at 30 June 2024. Cash and cash equivalents 128 265 • In June 2024, the Company successfully implemented a capital Trade receivables, net 62 100 ra

  6. Slide 6: Financial Overview

    6 Financial Overview Disciplined OPEX management and a return to revenue growth are projected to achieve a break-even position in 1H FY25. US$000’s Key Metrics 1H FY24 vs. 1H FY23 FINANCIAL RESULTS • Forecasted Revenue Recovery: Revenues have shown 2128 quarter-on-quarter recovery in 1HFY and are pr

  7. Slide 7: Channel Mix Optimisation

    7 Channel Mix Optimisation With 90% of Group Revenue generated from e-Commerce, there is significant upside potential for growth through in-store retail expansion. 1H FY24 Channel Analysis FY24 SALES BY CHANNEL • E-Commerce sales, including Direct-To-Consumer, represent 90% of Group Revenue. 4%3% •

  8. Slide 8: FY25 Planned Segment Diversification

    8 FY25 Planned Segment Diversification FY25 plans include expanding in-store retail footprint and integrating Healthy Chef® into the product mix. Balanced Product and Channel Mix FY25 PROJECTED SALES CONTRIBUTION • Continued growth in core e-Commerce channels (Amazon Amazon and Direct-To-Consumer We

  9. Slide 9: Gross Margin Growth Drivers

    9 Gross Margin Growth Drivers The Group’s gross margin is projected to improve from 38%1 in 1H FY24 to over 50% in FY25. Tactical Plan for Margin Improvement Margin enhancement will be achieved through: 1. Premium Price Strategy: Implementing a premium pricing model for Healthy Heights® in Q4 FY24.

  10. Slide 10: Operational Scorecard

    10 Operational Scorecard Disciplined operational management of key priorities planned for 2H FY24 and 1H FY25 to return the business to profitable growth and achieve positive operational cashflow. Key Priorities Goal Action Status Timing Achieve US$380k • Increase Healthy Heights® e-Commerce and ret

  11. Slide 11: Brand Portfolio Expansion Strategy

    11 Brand Portfolio Expansion Strategy The Company is pursuing a capital-light growth strategy whereby NGS becomes the exclusive North American partner for synergistic Australian brands with high potential in the U.S. marketplace. Owned Hero Brand USA Licenced Brands NGS 1H FY24 RESULTS

  12. Slide 12: The Healthy Chef Strategic Partnership

    12 The Healthy Chef Strategic Partnership In July 2024, NGS entered an exclusive IP Licence Agreement to produce and sell Healthy Chef ® products in North America. Increased revenue expected to be >US$1.5m in 1st year of trading The exclusive IP Licence will enable the Company to maximise its USA in

  13. Slide 13: Board and Management

    13 Board and Management STEPHEN TURNER ROB VALERIO DAVE FENLON PETER OSBORNE CEO & MANAGING DIRECTOR CFO NON-EXECUTIVE CHAIRMAN NON-EXECUTIVE DIRECTOR >20 years of Consumer Goods Overseen all accounting With over 30 years’ experience in Highly credential leader and business experience in executive r

  14. Slide 14: Strategic Priorities

    14 Strategic Priorities Targeting sustained profitability and growth in FY25. KEY FOCUS AREAS: 1. Revenue Growth: Targeting a minimum of US$380k per month by the end of FY24. 2. Gross Margin Improvement: Aiming for over 50%, driven primarily by the expansion of the Healthy Chef portfolio. 3. Cost Di

  15. Slide 15: Contact

    Contact Stephen Turner CEO & Managing Director steve@ngsolutions.co www.ngsolutions.co

Nutritional Growth Solutions — Investor Presentation (August 2024) on 6ix